NCT07521059已完成不适用
Short-Term Safety of Low-Dose Creatine Hydrochloride: A 28-Day Single-Arm Pilot Study
Vireo Systems, Inc.1 个研究点 分布在 1 个国家目标入组 11 人开始时间: 2024年5月30日最近更新:
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 11
- 试验地点
- 1
- 主要终点
- No adverse events
研究概览
简要总结
Background: Creatine monohydrate (typically 5-20 g/day) has a well-established safety profile across diverse populations. Creatine hydrochloride (CR-HCl) is a highly soluble creatine formulation that may allow effective supplementation at substantially lower doses (750 mg - 3 g/day); however, controlled human safety data specific to CR-HCl remain limited.
Objective: To evaluate the short-term laboratory safety and tolerability of low-dose CR-HCl supplementation administered for 28 days in healthy adults.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 60 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •healthy adults
排除标准
- •consumed creatine supplements in last 30 days significant medical conditions that could affect outcomes (e.g., diabetes)
研究组 & 干预措施
Group A 750mg/day
Experimental
干预措施: creatine supplementation (Dietary Supplement)
结局指标
主要结局
No adverse events
时间窗: over 28 days
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A Phase I, Single-arm, Open-label, Dose-escalation Study to Evaluate the Safety and Tolerability of Orialpha (BD-C) in Healthy Adult VolunteersBreast CancerNCT07300202Oriplantee Company Limited15
招募中
不适用
Effect Of Different Sodium Hypochlorite Concentrations On Intracanal Substance P, CGRP And Opiorphin Levels And Postoperative Pain During Root Canal RetreatmentNCT07453576KEZBAN MELTEM ÇOLAK60
招募中
不适用
Efficacy and Safety of HN2302 in Refractory Myasthenia Gravis(MG)NCT07413835The Affiliated Hospital of Xuzhou Medical University6
招募中
1 期
Luspatercept for the Treatment of Anemia Following Allogeneic Hematopoietic Stem Cell Transplantation(Allo-HSCT)Acute LeukemiaNCT07362095Zhujiang Hospital46
Enrolling By Invitation
不适用
"Real-world Assessment of BP Control in Patients With Hypertension by the Netrod RDN System" - REACH-RDNHypertensionNCT07273877Shanghai Golden Leaf MedTec Co. Ltd1,000